Previous Close | 4.31 |
1-Year Change | 33.02% |
6-Months Change | 48.11% |
3-Months Change | 9.67% |
Moving Avg (50d) | 4.8348 |
Moving Avg (200d) | 3.6968 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 301.0M |
Beta (3-Years) | 2.04 |
Revenue Growth (ttm) | -44.27% |
Net Profit Margin (ttm) | -110.4% |
Return On Assets (ttm) | -52.86% |
EPS (ttm) | -1.2 |
PE Ratio (ttm) | -3.59 |
Dividend Yield | % |
Asset Description: | Codexis, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-01-24 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
4.396 | 4.525 | 4.612 | 4.741 | 4.956 | 5.172 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |